Expand UTHR Menu
UTHR MENU

UTHR Stock Posts


Unusual Option Volume

UTHR United Therapeutics584.68-3.68 (-0.6%)

United Therapeutics trades 4,660 contracts. The highest volume is in the 17-Apr-26 610 calls, which is 4.3% above the current price.
Unusual Option Volume

UTHR United Therapeutics584.98+62.15 (+11.9%)

United Therapeutics trades 913 contracts. The company has the following event: American Thoracic Society Annual Meeting between May 1, 2026 and May 31, 2026. News: United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
Unusual Option Volume

UTHR United Therapeutics540.68-4.03 (-0.7%)

United Therapeutics trades 4,389 contracts. The highest volume is in the 17-Apr-26 420 puts. News: United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
Unusual Option Volume

UTHR United Therapeutics547.53+18.36 (+3.5%)

United Therapeutics trades 7,588 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

UTHR United Therapeutics519.15+40.99 (+8.6%)

United Therapeutics trades 2,944 contracts. The company has the following event: Leerink Global Healthcare Conference on Mar 9, 2026. News: United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
Unusual Option Volume

UTHR United Therapeutics513.85+9.95 (+2.0%)

United Therapeutics trades 4,162 contracts. The company has the following event: TD Cowen 46th Annual Health Care Conference on Mar 2, 2026. News: United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
Market Data Delayed 15 Minutes